Q/C Technologies Inc Dossier
Qualitative Analysis
Business overview
Q/C Technologies, Inc. (formerly TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., and Akers Biosciences, Inc.) is a Delaware corporation headquartered in New York, NY. The company has undergone a major strategic pivot, transitioning from its legacy clinical-stage pharmaceutical operations (developing Isomyosamine and Supera-CBD therapeutics) to building energy-efficient blockchain, cryptocurrency, and artificial intelligence infrastructure. This new computing-focused business model is anchored by an exclusive global licensing agreement with LightSolver Ltd. to utilize innovative quantum-class, laser-based processing units (LPUs) and silicon photonic computing architectures. Q/C Technologies aims to overcome the bandwidth, energy, and scalability limitations of traditional electronic GPU architectures by performing complex matrix multiplications naturally via optical interference.
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
An initiative to design and prototype a proprietary optical processing unit (OPU) to address performance and energy constraints in artificial intelligence (AI) inference infrastructure. The OPU leverages silicon photonic computing architecture to perform matrix multiplication naturally via optical interference, aiming to achieve lower propagation latency and minimal energy requirements compared to traditional electronic GPUs.
Expected impact: Aims to overcome key bottlenecks in bandwidth, energy efficiency, and scalability for AI workloads by bypassing traditional electronic GPU limitations.
A complete corporate transformation and rebranding from TNF Pharmaceuticals, Inc. to Q/C Technologies, Inc. to focus on energy-efficient blockchain, cryptocurrency infrastructure, and quantum-class laser-based computing.
Expected impact: Positions the company as a pioneer in optical and quantum-class computing, moving away from its legacy pharmaceutical programs.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
Provides Q/C Technologies with exclusive global rights to LightSolver's laser processing unit (LPU) technology for cryptocurrency and blockchain applications, enabling the development of the Q/C-branded qc-LPU100™.
Terms: Under the Membership Interest Purchase Agreement (MIPA) and licensing terms, Q/C became the first client to adapt LightSolver's LPU technology.
Martin Shkreli serves as a Strategic Advisor to provide technology evaluation, identify industry experts at the executive and board level, and assist with potential acquisitions to strengthen Q/C's position in computing and blockchain.
Terms: 12-month agreement starting December 8, 2025, involving a monthly fee and the issuance of warrants and restricted shares to the consultant.